AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AtriCure, Inc. Director's Dealing 2013

Jan 24, 2013

31802_dirs_2013-01-24_9cad0631-2236-4aa5-9ced-61798fa69270.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-11-01

Reporting Person: Wade M. Andrew (VP and Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7758	Direct

Footnotes

F1: Includes 1,938 shares acquired under the AtriCure, Inc. 2008 Employee Stock Purchase Plan.